Icd Primary Prevention denied as duplicate or overlapping therapy by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for icd primary prevention are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Denies an ICD as Duplicate Therapy — and Why You Can Appeal

A "duplicate therapy" denial for a primary-prevention implantable cardioverter-defibrillator (ICD) typically means UnitedHealthcare believes another existing device or therapy already covers the same clinical function. The most common scenario: a patient already has a wearable cardioverter-defibrillator (WCD), a cardiac resynchronization therapy defibrillator (CRT-D) with overlapping defibrillation capability, or a previously implanted device the plan believes remains functional. This denial reason is frequently incorrect or outdated — your cardiologist's clinical judgment about the distinct roles of these therapies is central to your appeal.

## Your Federal Appeal Rights

Under ACA §2719, fully-insured members may request external review by an independent review organization (IRO) after completing UHC's internal appeal process — ordinarily within four months of the final internal denial. ERISA §503 guarantees self-funded plan participants a full-and-fair review. If your condition is life-threatening or rapidly deteriorating, request expedited external review, which must be completed within 72 hours under federal rules.

## Concrete Appeal Process

1. Request the written denial specifying which existing therapy UHC considers duplicative. 2. Obtain UHC's ICD coverage determination guideline (available in UHC's Coverage Determination Guidelines library) and identify the language on device duplication. 3. File a Level 1 internal appeal within the timeframe stated on your denial notice. 4. If upheld, file Level 2 (if available under your plan), then request external review.

## Documentation to Gather

• Device history: records of any prior or current devices (WCD, pacemaker, CRT, prior ICD), including implant dates, current programming, and battery status.
• Clinical distinction letter: a letter from your electrophysiologist or cardiologist explaining the specific, non-duplicated clinical function the requested ICD would provide — distinct from any existing device.
• Arrhythmia and cardiac function records: most recent ECG, Holter monitor data, echocardiogram, and any EP study results relevant to primary-prevention risk stratification.
• Guideline organization reference: your physician may reference the applicable ACC/AHA guideline recommendations for primary-prevention ICD implantation generically, without fabricating trial names or percentages.

## Criteria-Mapping Structure

Copy UHC's duplicate-therapy exclusion language verbatim, then address each element:

| UHC Policy Language (verbatim) | Clinical Facts Supporting Appeal | |---|---| | [Paste relevant policy text] | [Specific chart finding, device record, or physician statement] |